NCT06771921View on ClinicalTrials.gov

A First-in-Human Trial of Safety and Efficacy of GEN1078 in Participants With Solid Tumors

PHASE1/PHASE2TerminatedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

January 29, 2025

Primary Completion Date

June 11, 2025

Study Completion Date

June 11, 2025

Conditions
Malignant Solid Tumor
Interventions
DRUG

GEN1078

Specified dose on specified days.

Trial Locations (6)

Unknown

Righshospitalet (Copenhagen University Hospital), Copenhagen

Hospital Universitari Vall d'Hebron, Barcelona

Centro Integral Oncologico Clara Campal, Madrid

Hospital Universitary Fundacion Jimenez Diaz, Madrid

NEXT Oncology Madrid, Madrid

Clinica Universidad de Navarra, Pamplona

Sponsors

Lead Sponsor

Genmab
All Listed Sponsors
lead

Genmab

INDUSTRY

NCT06771921 - A First-in-Human Trial of Safety and Efficacy of GEN1078 in Participants With Solid Tumors | Biotech Hunter | Biotech Hunter